Rare diseases
Investigational molecules
Locations
Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
PolandStudy on Ublituximab for Patients with Relapsing Multiple Sclerosis
PolandEvaluation of Tirzepatide Versus Placebo in Adolescents with Obesity or Overweight and Weight-Related Comorbidities: A Randomized, Double-Blind Clinical Trial
PolandEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
PolandStudy on Ritlecitinib for Adults and Adolescents with Nonsegmental Vitiligo
PolandStudy of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer
PolandWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
PolandGedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy
PolandJNJ-95597528 for Adults with Moderate to Severe Atopic Dermatitis
PolandA Phase 2 Study of JNJ-79635322 in Patients with Relapsed or Refractory Multiple Myeloma
PolandLong‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study
PolandStudy of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
